Biotechnology
and pharmaceutical companies are presented by a number of opportunities and
challenges by globalization. While R&D costs continue to rise and productivity
continues to fall, R&D organizations face hard choices. Many promising
projects are too expensive to pursue, and development-stage costs are creating
nearly insurmountable barriers to commercialization.
| |
| Pharmaceutical aompanies are now : |
|
● |
Establishing outsourcing and R&D programs in China to take advantage of talent and cost effecting an overall increase productivity |
● |
Actively seeking in-licensing candidates from Chinese innovators |
● |
Positioning for future market share |
|
| Biotechnology companies are now: |
|
● |
Investing the speed and lowering the cost of discovery and development through parthnerships and outsouring in China |
|
● |
Accessing Chinese innovations and pipeline |
|
●
|
Pressured by VC firms to outsource |
|
● |
Raising capital from Chinese investors |
|
|
|
|
| |
|
|
In order to realize increases in R&D productivity, access
talent and expertise at reasonable costs, and speed the development and commercialization
of technologies, R&D organizations must understand and seize the opportunities
that China offers. However, along with opportunity comes risk: cultural, legal,
and informational. China can be a demanding environment for partnership and
trust is something that must be built over time.
Success in China depends upon trusted local partners who understand
your business and science, can bridge cultures, have a distinct sense of strategy
and interests, have a network with local companies and the government, and
focus on important measures of success.
GB's biotechnology and pharmaceutical services
GB is the only professional services firm focused on bio-business
in China. Our industry expertise ranges across biotechnology, pharmaceuticals,
healthcare and chemicals. Our experience includes research and development,
strategic planning, development, execution, outsourcing management, and 'on
the ground' services. We can bring unique value to your firm because of our:
Primary focus on businesses that are impacted in some way
by biotechnology
Proprietary information flow from an exclusive database
and network
Unique service mix and ability to add value across the partnership,
outsourcing, and licensing chain
Understanding of Chinese and Western culture, strategy, business
practice, and science
GB provides the following services to its biotechnology and
pharmaceutical clients
Industry focus
Local presence, depth of knowledge and experience
Trusted solution provider with network
Ability to align our incentives with interests of clients
To find out more about our ability to work with your firm,
please contact info@generalbiologic.com.
